ArticleJAMA cardiology2025

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial.

Junichi Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.